Goldman Sachs Raises PT on Mindray Medical to $26.90

Symbols: MR
Share

Goldman Sachs has raised the price target on Mindray Medical (NYSE: MR) from $24.50 to $26.90 and maintains its Neutral rating.


 
 
< Previous
Dahlman Rose Initiates Precision Drilling at Buy
Next >
Credit Suisse Downgrades Choice Hotels International to Underperform
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust